165 related articles for article (PubMed ID: 21508143)
1. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.
Yim JH; Kim WB; Kim EY; Kim WG; Kim TY; Ryu JS; Gong G; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2011 Jul; 96(7):2049-56. PubMed ID: 21508143
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation.
Yim JH; Kim WB; Kim EY; Kim WG; Kim TY; Ryu JS; Moon DH; Sung TY; Yoon JH; Kim SC; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2011 Dec; 96(12):3695-700. PubMed ID: 21976723
[TBL] [Abstract][Full Text] [Related]
3. The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma.
Sun W; Di L; Chen L; Li D; Wu Y; Xiang J; Zhou S; Sun T
BMC Surg; 2022 Nov; 22(1):374. PubMed ID: 36324095
[TBL] [Abstract][Full Text] [Related]
4. Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma.
Lang BH; Wong KP; Wan KY
Ann Surg Oncol; 2013 Feb; 20(2):653-9. PubMed ID: 22956067
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
7. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
8. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.
Al-Saif O; Farrar WB; Bloomston M; Porter K; Ringel MD; Kloos RT
J Clin Endocrinol Metab; 2010 May; 95(5):2187-94. PubMed ID: 20332244
[TBL] [Abstract][Full Text] [Related]
10. Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer.
Hung ML; Wu JX; Li N; Livhits MJ; Yeh MW
JAMA Surg; 2018 Dec; 153(12):1098-1104. PubMed ID: 30140908
[TBL] [Abstract][Full Text] [Related]
11. Surgical and Biochemical Outcomes in Nerve Monitored Reoperation Surgery for Recurrent Papillary Thyroid Carcinoma.
Patel KR; Wang B; Abdelhamid Ahmed AH; Okose OC; Ma H; Behr IJ; Cheung AY; Saito Y; Kamani D; Silver Karcioglu A; Liddy W; Takami H; Cunnane M; Randolph GW
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1234-1240. PubMed ID: 37245079
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up.
Onuma AE; Beal EW; Nabhan F; Hughes T; Farrar WB; Phay J; Ringel MD; Kloos RT; Shirley LA
Ann Surg Oncol; 2019 Jun; 26(6):1737-1743. PubMed ID: 30820785
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
Clayman GL; Agarwal G; Edeiken BS; Waguespack SG; Roberts DB; Sherman SI
Thyroid; 2011 Dec; 21(12):1309-16. PubMed ID: 22136266
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
Yoo RE; Kim JH; Paeng JC; Park YJ
Medicine (Baltimore); 2018 Mar; 97(9):e0003. PubMed ID: 29489641
[TBL] [Abstract][Full Text] [Related]
15. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
[TBL] [Abstract][Full Text] [Related]
16. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma.
Kouvaraki MA; Lee JE; Shapiro SE; Sherman SI; Evans DB
Surgery; 2004 Dec; 136(6):1183-91. PubMed ID: 15657574
[TBL] [Abstract][Full Text] [Related]
17. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
[TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C
Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the risk of re-recurrence in patients with persistent/recurrent thyroid carcinoma after initial reoperation.
Xu S; Li Q; Wang Z; Huang H; Wang X; Liu S; Liu J
Surgery; 2021 Apr; 169(4):837-843. PubMed ID: 33127094
[TBL] [Abstract][Full Text] [Related]
20. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
Lang BH; Wong KP; Wan KY; Lo CY
Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
